Crossmark

MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention

Crossref DOI link: https://doi.org/10.1016/j.arbres.2023.09.009

Published Print: 2023-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lacámara, Sergio

Martin, Carlos
Funding

Funding for this research was provided by:

European Commission

European and Developing Countries Clinical Trials Partnership (RIA-2016-V-1637)

European and Developing Countries Clinical Trials Partnership (RIA2019S-2652)

International AIDS Vaccine Initiative

National Institutes of Health
License Information

Text and Data Mining valid from 2023-12-01

Text and Data Mining valid from 2023-12-01

Version of Record valid from 2023-11-07
More Information

This article is maintained by: Elsevier

Article Title: MTBVAC: A Tuberculosis Vaccine Candidate Advancing Towards Clinical Efficacy Trials in TB Prevention

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2023.09.009

Content Type: article

Copyright: © 2023 The Authors. Published by Elsevier España, S.L.U. on behalf of SEPAR.